Free light chains in multiple sclerosis urine

Multiple Sclerosis

Volumn 4, Issue 3, 1998, Pages 254-256

  Mehta, P D ^a   Cook, S D ^b   Coyle, P K ^c   Troiano, R A ^b   Constantinescu, C S ^d   Rostami, A M ^d  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Creatinine; Enzyme linked immunosorbent assay; Free light chains; Multiple sclerosis; Urine

Indexed keywords

IMMUNOGLOBULIN LIGHT CHAIN;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; URINALYSIS; URINE LEVEL;

EID: 0031683078     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859800400331     Document Type: Article

References (30)

1. Hafler DA, Weiner HL. (1989) MS; a CNS and systemic autoimmune disease, Immunol Today 10: 104 - 107.
2. Tourtellotte WW, Walsh MJ. (1984) Cerebrospinal fluid profile in multiple sclerosis. In: Poser CM (ed.). The diagnosis of multiple sclerosis. Thieme-Stratton: New York. pp. 165 - 178.
3. Link H. (1990) Immunological abnormalities in the cerebrospinal fluid in multiple sclerosis. Curr Opin Neurol Neurosurg 3: 199 - 203.
4. Mattson DH, Roos RP, Arnason BGW. (1981) Comparison of an agar gel electrophoresis and isoelectric focusing in multiple sclerosis and subacute sclerosing panencephalitis. Ann Neurol 9: 34 - 41.
5. Rifai N, Christenson RH, Gelman BB, Silverman LM. (1987) Changes in cerebrospinal fluid IgG and apolipoprotein E indices in patients with multiple sclerosis during demyelination and remyelination. Clin Chem 33: 1155 - 1157.
6. Soloman A. (1976) Bence-Jones proteins and light chains of immunoglobulins. New Engl J Med 294: 17 - 23 and 97 - 108.
7. Soloman A. (1986) Clinical implications of monoclonal light chains. Semin Oncol 13: 341 - 349.
8. Link H, Laurenzi MA. (1979) Immunoglobulin class and light chain type of oligoclonal bands in CSF in multiple sclerosis determined by agarose gel electrophoresis and immunofixation. Ann Neurol 6: 107 - 110.
9. Vakaet A, Thompson EJ. (1985) Free light chains in the cerebrospinal fluid: an indicator of recent immunological stimulation. J Neurol Neurosurg Psychiatry 48: 995 - 998.
10. Bracco et al. (1987) Free light chains in the CSF in multiple sclerosis. J Neurol 234: 303 - 307.
11. Rudick RA, Peter DR, Bidlack JM, Knutson DW. (1985) Multiple sclerosis: Free light chains in cerebrospinal fluid. Neurology 35: 1443 - 1449.
12. Rudick RA, Pallant A, Bidlack JM, Herndon RM. (1986) Free kappa light chains in multiple sclerosis spinal fluid. Ann Neurol 20: 63 - 69.
13. Rudick RA, French CA, Breton D, Williams GW. (1989) Relative diagnostic value of cerebrospinal fluid kappa chains in MS: comparison with other immunoglobulin tests. Neurology 39: 964 - 968.
14. DeCarli C, Menegus MA, Rudick RA. (1987) Free light chains in multiple sclerosis and infections of the CNS. Neurology 37: 1334 - 1338.
15. Kurtzke JF. (1983) Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33: 1444 - 1453.
16. McFarland HF et al. (1992) Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol 32: 758 - 766.
17. Hill GS, Morel-Maroger L, Mery JP. (1983) Renal lesions in multiple myeloma: their relationship to associated protein abnormalities. Am J Kidney Dis 2: 423 - 438.
18. Epstein WV, Tan M. (1966) Increase of L-chain proteins in the sera of patients with systemic lupus erythematosus and the synovial fluids of patients with peripheral rheumatoid arthritis. Arthritis Rheum 9: 713 - 719.
19. Cooper A, Bluestone R. (1968) Free immunoglobulin light chains in connective tissue diseases. Ann Rheum Dis 27: 537 - 543.
20. Pezzoli A, Pascali E. (1987) Bence Jones proteinuria in multiple sclerosis. Clin Chem 33: 1923 - 1924.
21. Mehta PD, Cook SD, Troiano RA, Coyle PK. (1991) Increased free light chains in the urine from patients with multiple sclerosis. Neurology 41: 540 - 544.
22. Hopper JE et al. (1989) Clinical relapse in systemic lupus erythematosus: correlation of antecedent deviation of urinary free light-chain immunoglobulin. J Clin Immunol 9: 338 - 350.
23. Constantinescu CS, Mehta PD, Rostami AM. (1994) Urinary free kappa light chain levels in chronic progressive multiple sclerosis. Pathobiology 62: 29 - 33.
24. Cohen SR, Brooks BR, Herndon RM, McKhann GM. (1980) A diagnostic index of active demyelination: myelin basic protein in cerebrospinal fluid. Ann Neurol 8: 25 - 31.
25. Whitaker JN. (1977) Myelin encephalitogenic protein fragments in cerebrospinal fluid of persons with multiple sclerosis. Neurology 27: 911 - 920.
26. Whitaker JN. (1984) Indicators of disease activity in multiple sclerosis. Studies of myelin basic protein-like materials. In: Scheinberg L, Raine CS (eds.). Multiple sclerosis: experimental and clinical aspects. The New York Academy of Sciences: New York, pp. 140 - 150.
27. Whitaker JN. (1987) The presence of immunoreactive myelin basic protein peptide in urine of persons with multiple sclerosis. Ann Neurol 22: 648 - 655.
28. Whitaker JN et al. (1995) Urinary myelin basic protein-like material as a correlate of the progression of multiple sclerosis. Ann Neurol 38: 625 - 632.
29. McKhann GM. (1990) Therapeutic trials for multiple sclerosis. Ann Neurol 27: 589 - 590.
30. Vaan den Noort S. N (1988) Future directions: where do we go from here? Neurology 38 (Suppl 2): 88.